{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:20:01Z","timestamp":1783027201690,"version":"3.54.6"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019126","name":"Gujarat Council on Science &amp; Technology","doi-asserted-by":"publisher","award":["XN8LQU"],"award-info":[{"award-number":["XN8LQU"]}],"id":[{"id":"10.13039\/100019126","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.arr.2026.103149","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:10:45Z","timestamp":1777306245000},"page":"103149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tiny Titans, big promise: Nanotechnology and microRNA in the fight against Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"119","author":[{"given":"Bhavya","family":"Nakum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruvi","family":"Vejpara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushboo","family":"Faldu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigna","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103149_bib1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/pharmaceutics14051003","article-title":"Novel luteolin-loaded chitosan decorated nanoparticles for brain-targeting delivery in a sporadic Alzheimer\u2019s disease mouse model: focus on antioxidant, anti-inflammatory, and amyloidogenic pathways","volume":"14","author":"Abbas","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2026.103149_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202302673","article-title":"Functional nanomaterials for the diagnosis of Alzheimer\u2019s disease: recent progress and future perspectives","volume":"33","author":"Abdullah","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.arr.2026.103149_bib3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/molecules23061241","article-title":"Design and efficacy of nanogels formulations for intranasal administration","volume":"23","author":"Aderibigbe","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2026.103149_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00665","article-title":"MicroRNAs in Alzheimer\u2019s disease: diagnostic markers or therapeutic agents?","volume":"10","author":"Angelucci","year":"2019","journal-title":"Front. Pharm."},{"key":"10.1016\/j.arr.2026.103149_bib5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/pharmaceutics15030898","article-title":"Dendrimers in Alzheimer\u2019s disease: recent approaches in multi-targeting strategies","volume":"15","author":"Arbez-Gindre","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2026.103149_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/17425247.2022.2063835","article-title":"Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications","volume":"19","author":"Asakiya","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.arr.2026.103149_bib7","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/antiox14070834","article-title":"Distinctive effects of fullerene c60 and fullerenol C60(OH)24 nanoparticles on histological, molecular and behavioral hallmarks of Alzheimer\u2019s disease in APPswe\/PS1E9 mice","volume":"14","author":"Askarova","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.arr.2026.103149_bib8","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2174\/1381612826666200311131658","article-title":"Nanoparticlized system: promising approach for the management of alzheimer\u2019s disease through intranasal delivery","volume":"26","author":"Bahadur","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.arr.2026.103149_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood\u2013brain barrier to blood\u2013brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2026.103149_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3233\/ADR-220112","article-title":"Metal nanoparticles in Alzheimer\u2019s disease","volume":"7","author":"Behera","year":"2023","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.arr.2026.103149_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2026.103149_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1049\/nbt2.12018","article-title":"Nanomicelles: types, properties and applications in drug delivery","volume":"15","author":"Bose","year":"2021","journal-title":"IET Nanobiotechnol"},{"key":"10.1016\/j.arr.2026.103149_bib13","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1039\/C7NR06808E","article-title":"Citrate stabilized gold nanoparticles interfere with amyloid fibril formation: D76N and \u0394N6 \u03b22-microglobulin variants","volume":"10","author":"Brancolini","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.arr.2026.103149_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.nano.2017.12.006","article-title":"Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer\u2019s disease-like transgenic mouse model","volume":"14","author":"Carradori","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.arr.2026.103149_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.576037","article-title":"Neuroinflammation treatment via targeted delivery of nanoparticles","volume":"14","author":"Cerqueira","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib16","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1080\/17425247.2024.2414768","article-title":"Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer\u2019s disease: current approaches and future perspectives","volume":"21","author":"Chakraborty","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.arr.2026.103149_bib17","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.7150\/thno.21529","article-title":"Nucleic acid-based theranostics for tackling Alzheimer\u2019s disease","volume":"7","author":"Chakravarthy","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.arr.2026.103149_bib18","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.3390\/pharmaceutics15092316","article-title":"A Promising approach: magnetic nanosystems for Alzheimer\u2019s disease theranostics","volume":"15","author":"Chaparro","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2026.103149_bib19","doi-asserted-by":"crossref","first-page":"e1534","DOI":"10.1016\/S2214-109X(24)00264-X","article-title":"The global macroeconomic burden of Alzheimer\u2019s disease and other dementias: estimates and projections for 152 countries or territories","volume":"12","author":"Chen","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.arr.2026.103149_bib20","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.nantod.2014.12.002","article-title":"Nanotopographical surfaces for stem cell fate control: Engineering mechanobiology from the bottom","volume":"9","author":"Chen","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.arr.2026.103149_bib21","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1038\/onc.2010.193","article-title":"Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression","volume":"29","author":"Chen","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.arr.2026.103149_bib22","article-title":"Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer\u2019s disease \u2013 a cross-validation study","volume":"28","author":"Chiu","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.arr.2026.103149_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/s12979-019-0150-2","article-title":"RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer\u2019s disease","volume":"16","author":"Cui","year":"2019","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.arr.2026.103149_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.168038","article-title":"CART and Ceria nanozyme co-loaded ROS-responsive nanogel for synergistic treatment of Alzheimer\u2019s disease","volume":"522","author":"Dai","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.arr.2026.103149_bib25","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3390\/pharmaceutics14040756","article-title":"Intranasal cerium oxide nanoparticles ameliorate cognitive function in rats with Alzheimer\u2019s via anti-oxidative pathway","volume":"14","author":"Danish","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2026.103149_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70389","article-title":"MiRNA-501-3p and MiRNA-502-3p: a promising biomarker panel for Alzheimer\u2019s disease","volume":"15","author":"Devara","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.arr.2026.103149_bib27","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/nar\/gkad1142","article-title":"The miRNA\u2013target interactions: an underestimated intricacy","volume":"52","author":"Diener","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.arr.2026.103149_bib28","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s10072-024-07871-4","article-title":"Nanomedicine in the treatment of Alzheimer\u2019s disease: bypassing the blood-brain barrier with cutting-edge nanotechnology","volume":"46","author":"Dong","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2026.103149_bib29","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s10072-024-07871-4","article-title":"Nanomedicine in the treatment of Alzheimer\u2019s disease: bypassing the blood-brain barrier with cutting-edge nanotechnology","volume":"46","author":"Dong","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2026.103149_bib30","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/cdd.2014.72","article-title":"Cerium oxide nanoparticles protect against A\u03b2-induced mitochondrial fragmentation and neuronal cell death","volume":"21","author":"Dowding","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.arr.2026.103149_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201801852","article-title":"Near-infrared switchable fullerene-based synergy therapy for Alzheimer\u2019s disease","volume":"14","author":"Du","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.arr.2026.103149_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116836","article-title":"Exploring the molecular mechanisms of MSC-derived exosomes in Alzheimer\u2019s disease: autophagy, insulin and the PI3K\/Akt\/mTOR signaling pathway","volume":"176","author":"Ebrahim","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2026.103149_bib33","doi-asserted-by":"crossref","first-page":"18009","DOI":"10.1039\/D1RA01725J","article-title":"Green-synthesized zinc oxide nanoparticles, anti-Alzheimer potential and the metabolic profiling of Sabal blackburniana grown in Egypt supported by molecular modelling","volume":"11","author":"El-Hawwary","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.arr.2026.103149_bib34","first-page":"549","article-title":"Polymeric nanoparticles: a promising strategy for treatment of Alzheimer\u2019s disease","volume":"19","author":"Elmahboub","year":"2024","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"10.1016\/j.arr.2026.103149_bib35","doi-asserted-by":"crossref","first-page":"14879","DOI":"10.1073\/pnas.0803230105","article-title":"A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence","volume":"105","author":"Forman","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.arr.2026.103149_bib36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12951-025-03251-y","article-title":"Responsive nanoparticles synergize with Curcumin to break the \u201creactive oxygen Species-Neuroinflammation\u201d vicious cycle, enhancing traumatic brain injury outcomes","volume":"23","author":"Fu","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.arr.2026.103149_bib37","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jat.4795","article-title":"The molecular mechanism of miRNA-195-5p regulating ERK involvement in abnormal phosphorylation of TAu Protein by Aluminum Maltol in PC12 cells","volume":"45","author":"Gao","year":"2025","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.arr.2026.103149_bib38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/bios13090880","article-title":"SERS-BAsed Optical Nanobiosensors for the Detection of Alzheimer\u2019s disease","volume":"13","author":"Gao","year":"2023","journal-title":"Biosens."},{"key":"10.1016\/j.arr.2026.103149_bib39","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103149_bib40","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3349\/ymj.2018.59.9.1096","article-title":"Inhibition of miR-128 Abates A\u03b2-mediated cytotoxicity by targeting PPAR-\u03b3 via NF-\u03baB inactivation in primary mouse cortical neurons and Neuro2a cells","volume":"59","author":"Geng","year":"2018","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.arr.2026.103149_bib41","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1021\/acs.bioconjchem.9b00505","article-title":"Lactoferrin coupled lower generation PAMAM dendrimers for brain targeted delivery of memantine in aluminum-chloride-induced Alzheimer\u2019s disease in mice","volume":"30","author":"Gothwal","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.arr.2026.103149_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103691","article-title":"Antisense oligonucleotides for Alzheimer\u2019s disease therapy: from the mRNA to miRNA paradigm","volume":"74","author":"Grabowska-Pyrzewicz","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2026.103149_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/jnt6020010","article-title":"Nanotheranostics revolutionizing gene therapy: emerging applications in gene delivery enhancement","volume":"6","author":"Guzm\u00e1n-Sastoque","year":"2025","journal-title":"J. Nanotheranostics"},{"key":"10.1016\/j.arr.2026.103149_bib44","article-title":"Emerging Alzheimer\u2019s disease treatment paradigms: a late-stage clinical trial review","volume":"10","author":"Hl\u00e1vka","year":"2024","journal-title":"Alzheimer\u2019S Dement. Transl. Res. & Clin. Interv."},{"key":"10.1016\/j.arr.2026.103149_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrg2936","article-title":"Gene silencing by microRNAs: contributions of translational repression and mRNA decay","volume":"12","author":"Huntzinger","year":"2011","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.arr.2026.103149_bib46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1208\/s12249-020-01652-w","article-title":"Combined therapy for Alzheimer\u2019s disease: tacrine and PAMAM dendrimers co-administration reduces the side effects of the drug without modifying its activity","volume":"21","author":"Igart\u00faa","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.arr.2026.103149_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114968","article-title":"siRNA drug delivery across the blood\u2013brain barrier in Alzheimer\u2019s disease","volume":"199","author":"Imran Sajid","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2026.103149_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12951-025-03109-3","article-title":"Drug delivery strategies with lipid-based nanoparticles for Alzheimer\u2019s disease treatment","volume":"23","author":"Jang","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.arr.2026.103149_bib49","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3762\/bjnano.9.98","article-title":"Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations","volume":"9","author":"Jeevanandam","year":"2018","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.arr.2026.103149_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069351","article-title":"MiR-146a regulates sod2 expression in H2O2 Stimulated PC12 Cells","volume":"8","author":"Ji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2026.103149_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1510798","article-title":"Engineered nanoparticles for the treatment of Alzheimer\u2019s disease","volume":"16","author":"Jia","year":"2025","journal-title":"Front. Pharm."},{"key":"10.1016\/j.arr.2026.103149_bib52","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neuropharm.2016.04.046","article-title":"Osthole decreases beta amyloid levels through up-regulation of miR-107 in Alzheimer\u2019s disease","volume":"108","author":"Jiao","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2026.103149_bib53","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.3390\/ijms21093272","article-title":"Combination drug therapy for the management of Alzheimer\u2019s disease","volume":"21","author":"Kabir","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103149_bib54","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.2147\/IJN.S454553","article-title":"Brain targeting nanomedicines: pitfalls and promise","volume":"19","author":"Kakinen","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.arr.2026.103149_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102497","article-title":"AI-driven innovations in Alzheimer\u2019s disease: integrating early diagnosis, personalized treatment, and prognostic modelling","volume":"101","author":"Kale","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103149_bib56","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2147\/IJN.S191878","article-title":"Superparamagnetic iron oxide nanoparticles combined with NGF and quercetin promote neuronal branching morphogenesis of PC12 cells","volume":"14","author":"Katebi","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.arr.2026.103149_bib57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11011-023-01265-9","article-title":"Understanding the multifaceted role of miRNAs in Alzheimer\u2019s disease pathology","volume":"39","author":"Kaur","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.arr.2026.103149_bib58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11011-023-01265-9","article-title":"Understanding the multifaceted role of miRNAs in Alzheimer\u2019s disease pathology","volume":"39","author":"Kaur","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.arr.2026.103149_bib59","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.2147\/IJN.S239608","article-title":"Transferrin-modified osthole PEGylated liposomes travel the blood-brain barrier and mitigate alzheimer\u2019s disease-related pathology in APP\/PS-1 mice","volume":"15","author":"Kong","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.arr.2026.103149_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4161\/rna.6.1.7534","article-title":"MicroRNAs identified in highly purified liver-derived mitochondria may play a role in apoptosis","volume":"6","author":"Kren","year":"2009","journal-title":"RNA Biol."},{"key":"10.1016\/j.arr.2026.103149_bib61","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.3233\/JAD-190583","article-title":"A new discovery of microRNA-455-3p in Alzheimer\u2019s disease","volume":"72","author":"Kumar","year":"2019","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103149_bib62","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1021\/acsnano.5b08045","article-title":"Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer\u2019s disease","volume":"10","author":"Kwon","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.arr.2026.103149_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.939855","article-title":"Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer\u2019s disease: Current trends and future perspectives","volume":"16","author":"La Barbera","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib64","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/JAD-2011-102016","article-title":"Potentiation of tau aggregation by cdk5 and GSK3\u03b2","volume":"26","author":"Lee","year":"2011","journal-title":"J. Alzheimer\u2019S Dis."},{"key":"10.1016\/j.arr.2026.103149_bib65","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1038\/s41467-023-43995-5","article-title":"Amplified fluorogenic immunoassay for early diagnosis and monitoring of Alzheimer\u2019s disease from tear fluid","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103149_bib66","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2013-14-7-r78","article-title":"A blood based 12-miRNA signature of Alzheimer disease patients","volume":"14","author":"Leidinger","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.arr.2026.103149_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2013-14-7-r78","article-title":"A blood based 12-miRNA signature of Alzheimer disease patients","volume":"14","author":"Leidinger","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.arr.2026.103149_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132019","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib69","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s10072-025-08051-8","article-title":"miRNAs in neurodegenerative diseases: from target screening to precision therapy","volume":"46","author":"Liao","year":"2025","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2026.103149_bib70","doi-asserted-by":"crossref","first-page":"46290","DOI":"10.1021\/acsami.2c13129","article-title":"Dendrimer\u2013siRNA Conjugates for Targeted Intracellular delivery in glioblastoma animal models","volume":"14","author":"Liyanage","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.arr.2026.103149_bib71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.colsurfb.2016.04.041","article-title":"Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer\u2019s disease treatment","volume":"145","author":"Loureiro","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.arr.2026.103149_bib72","article-title":"Microenvironment remodeling micelles for Alzheimer\u2019s disease therapy by early modulation of activated microglia","volume":"6","author":"Lu","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.arr.2026.103149_bib73","article-title":"Microenvironment remodeling micelles for Alzheimer\u2019s disease therapy by early modulation of activated microglia","volume":"6","author":"Lu","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.arr.2026.103149_bib74","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-3659(02)00020-2","article-title":"The effect of poly(ethylene glycol)\u2013poly(d,l-lactic acid) diblock copolymers on peptide acylation","volume":"80","author":"Lucke","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2026.103149_bib75","doi-asserted-by":"crossref","first-page":"31315","DOI":"10.1074\/jbc.M805371200","article-title":"An NF-\u03baB-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer disease and in stressed human brain cells","volume":"283","author":"Lukiw","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103149_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1058780","article-title":"Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer\u2019s disease","volume":"14","author":"Ma","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032616","article-title":"Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease","volume":"7","author":"Mathew","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2026.103149_bib78","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Mater. Au"},{"key":"10.1016\/j.arr.2026.103149_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-201027","article-title":"Selective secretase targeting for Alzheimer\u2019s disease therapy","volume":"81","author":"Miranda","year":"2021","journal-title":"J. Alzheimer\u2019S Dis."},{"key":"10.1016\/j.arr.2026.103149_bib80","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1007\/s12035-024-04135-2","article-title":"A comprehensive review of membrane transporters and microRNA regulation in Alzheimer\u2019s disease","volume":"61","author":"Mishra","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103149_bib81","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/pharmaceutics15041054","article-title":"Dendrimers and derivatives as multifunctional nanotherapeutics for Alzheimer\u2019s disease","volume":"15","author":"Moreira","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2026.103149_bib82","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1007\/s12035-015-9156-8","article-title":"MicroRNA-29a Is a candidate biomarker for Alzheimer\u2019s disease in cell-free cerebrospinal fluid","volume":"53","author":"M\u00fcller","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103149_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1405423","article-title":"Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer\u2019s disease","volume":"15","author":"Muolokwu","year":"2024","journal-title":"Front. Pharm."},{"key":"10.1016\/j.arr.2026.103149_bib84","doi-asserted-by":"crossref","DOI":"10.2174\/1566523217666170510155803","article-title":"Nucleic acids-based nanotherapeutics crossing the blood brain barrier","volume":"17","author":"Nafee","year":"2017","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.arr.2026.103149_bib85","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3233\/JAD-2008-13210","article-title":"Nanotechnology solutions for Alzheimer\u2019s disease: advances in research tools, diagnostic methods and therapeutic agents","volume":"13","author":"Nazem","year":"2008","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103149_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-05372-8","article-title":"Elevated miRNA-21, miRNA-155, and miRNA-182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy development","volume":"15","author":"Nikanfar","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103149_bib87","doi-asserted-by":"crossref","DOI":"10.1155\/np\/9581369","article-title":"Circular RNAs, miRNAs, and Exosomes: their roles and importance in amyloid-beta and tau pathologies in Alzheimer\u2019s disease","volume":"2025","author":"Pala","year":"2025","journal-title":"Neural Plast."},{"key":"10.1016\/j.arr.2026.103149_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1946","article-title":"Advances in nanoprobes for molecular MRI of Alzheimer\u2019s disease","volume":"16","author":"Parekh","year":"2024","journal-title":"WIREs Nanomed. Nanobiotechnology"},{"key":"10.1016\/j.arr.2026.103149_bib89","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.addr.2011.12.006","article-title":"Polymeric nanoparticles for drug delivery to the central nervous system","volume":"64","author":"Patel","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2026.103149_bib90","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12017-024-08820-2","article-title":"Recent advances in the miRNA-mediated regulation of neuronal differentiation and death","volume":"26","author":"Patranabis","year":"2024","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.arr.2026.103149_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19862-6","article-title":"Plasma microRNAs as potential biomarkers in early Alzheimer disease expression","volume":"12","author":"Pe\u00f1a-Bautista","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103149_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-72096-6","article-title":"NACC2, a molecular effector of miR-132 regulation at the interface between adult neurogenesis and Alzheimer\u2019s disease","volume":"14","author":"Penning","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103149_bib93","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.3390\/nano13192697","article-title":"Polyoxometalate-decorated gold nanoparticles inhibit \u03b2-amyloid aggregation and cross the blood\u2013brain barrier in a \u00b5physiological model","volume":"13","author":"Perx\u00e9s Perich","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.arr.2026.103149_bib94","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14737159.2021.1887732","article-title":"Nanomaterial-based optical and electrochemical biosensors for amyloid beta and tau: potential for early diagnosis of Alzheimer\u2019s disease","volume":"21","author":"Phan","year":"2021","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.arr.2026.103149_bib95","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biomaterials.2015.11.057","article-title":"Ionizing radiation-engineered nanogels as insulin nanocarriers for the development of a new strategy for the treatment of Alzheimer\u2019s disease","volume":"80","author":"Picone","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.arr.2026.103149_bib96","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.nbd.2011.10.003","article-title":"REM sleep behavior disorder: from dreams to neurodegeneration","volume":"46","author":"Postuma","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103149_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.01019","article-title":"Transcytosis to cross the blood brain barrier, new advancements and challenges","volume":"12","author":"Pulgar","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114822","article-title":"Magnetic iron oxide nanoparticles for brain imaging and drug delivery","volume":"197","author":"Qiao","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.arr.2026.103149_bib99","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.molmed.2024.07.004","article-title":"MicroRNAs: a symphony orchestrating evolution and disease dynamics","volume":"31","author":"Quah","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.arr.2026.103149_bib100","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1046\/j.1460-9568.2000.00078.x","article-title":"Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells","volume":"12","author":"Ramge","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib101","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/13872877241313397","article-title":"MicroRNA-based recent research developments in Alzheimer\u2019s disease","volume":"104","author":"Ramirez-Gomez","year":"2025","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103149_bib102","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3762\/bjnano.16.44","article-title":"Nanomaterials in targeting amyloid-\u03b2 oligomers: current advances and future directions for Alzheimer\u2019s disease diagnosis and therapy","volume":"16","author":"Randhawa","year":"2025","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.arr.2026.103149_bib103","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10571-022-01200-z","article-title":"Roles of the miR-155 in Neuroinflammation and Neurological Disorders: a potent biological and therapeutic target","volume":"43","author":"Rastegar-Moghaddam","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103149_bib104","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2012.08.003","article-title":"Cell-to-cell miRNA transfer: from body homeostasis to therapy","volume":"136","author":"Redis","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.arr.2026.103149_bib105","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/pharmaceutics17040502","article-title":"AChE inhibition capability of nanogels derived from natural molecules: tannic acid and lysine for Alzheimer\u2019s disease","volume":"17","author":"Sahiner","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.arr.2026.103149_bib106","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1021\/acschemneuro.8b00622","article-title":"Impact of gold nanoparticles on amyloid \u03b2-induced Alzheimer\u2019s disease in a rat animal model: involvement of STIM proteins","volume":"10","author":"Sanati","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib107","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI78421","article-title":"Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau","volume":"125","author":"Santa-Maria","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.arr.2026.103149_bib108","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2026.103149_bib109","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/brainsci14020130","article-title":"Nanoencapsulated curcumin: enhanced efficacy in reversing memory loss in An Alzheimer disease model","volume":"14","author":"Savall","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.arr.2026.103149_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2025.112063","article-title":"miR-132\u20133p is down-regulated in plasma and CD171+ extracellular vesicles isolated from patients with mild Alzheimer\u2019s disease","volume":"225","author":"Sbriscia","year":"2025","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.arr.2026.103149_bib111","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/0115672050386593250521064527","article-title":"Evaluating the therapeutic effects of oxytocin on animal model of Alzheimer\u2019s disease: a systematic review","volume":"22","author":"Shafigh","year":"2025","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2026.103149_bib112","doi-asserted-by":"crossref","unstructured":"Shah, P., Cho, S.K., Thulstrup, P.W., Bjerrum, M.J., Lee, P.H., Kang, J.-H., Bhang, Y.-J., Yang, S.W., 2017. MicroRNA Biomarkers in Neurodegenerative Diseases and Emerging Nano-Sensors Technology. https:\/\/doi.org\/10.14802\/jmd.16037\/J.","DOI":"10.14802\/jmd.16037"},{"key":"10.1016\/j.arr.2026.103149_bib113","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1039\/D2NA00625A","article-title":"Advanced nanomaterials for modulating Alzheimer\u2019s related amyloid aggregation","volume":"5","author":"Shao","year":"2023","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.arr.2026.103149_bib114","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1517\/17425255.2012.637916","article-title":"Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems","volume":"8","author":"Sharma","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.arr.2026.103149_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2024.105685","article-title":"Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: implications for alzheimer\u2019s disease pathogenesis","volume":"161","author":"Sharma","year":"2024","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.arr.2026.103149_bib116","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.2147\/IJN.S417928","article-title":"Combined donepezil with astaxanthin via nanostructured lipid carriers effective delivery to brain for Alzheimer\u2019s disease in rat model","volume":"18","author":"Shehata","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.arr.2026.103149_bib117","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1002\/adfm.200901539","article-title":"Integrated multifunctional nanosystems for medical diagnosis and treatment","volume":"19","author":"Shi","year":"2009","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.arr.2026.103149_bib118","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1471-4159.2011.07333.x","article-title":"Up-regulation of the mitochondrial malate dehydrogenase by oxidative stress is mediated by miR-743a","volume":"118","author":"Shi","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2026.103149_bib119","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","article-title":"Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management","volume":"367","author":"Singh","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2026.103149_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2015.00061","article-title":"miR-155 is involved in Alzheimer\u2019s disease by regulating T lymphocyte function","volume":"7","author":"Song","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib121","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/alz.12214","article-title":"Development and validation of the Uniform Data Set (v3.0) executive function composite score (UDS3-EF)","volume":"17","author":"Staffaroni","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.arr.2026.103149_bib122","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13195-019-0506-z","article-title":"Brain volumes and cortical thickness on MRI in the finnish geriatric intervention study to prevent cognitive impairment and disability (FINGER)","volume":"11","author":"Stephen","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2026.103149_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01165","article-title":"Intranasal delivery of targeted nanoparticles loaded with mir-132 to brain for the treatment of neurodegenerative diseases","volume":"11","author":"Su","year":"2020","journal-title":"Front. Pharm."},{"key":"10.1016\/j.arr.2026.103149_bib124","first-page":"59","article-title":"Exploring Intervention techniques for Alzheimer\u2019s disease: conventional methods and the role of AI in advancing care","volume":"2","author":"Subramanian","year":"2024","journal-title":"Artif. Intell. Appl."},{"key":"10.1016\/j.arr.2026.103149_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102310","article-title":"Blood-brain barrier penetrating nanosystems enable synergistic therapy of glioblastoma","volume":"56","author":"Sun","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.arr.2026.103149_bib126","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12951-023-02095-8","article-title":"Magnetic separation and concentration of A\u03b2 1\u201342 molecules dispersed at the threshold concentration for Alzheimer\u2019s disease diagnosis in clinically-relevant volumes of sample","volume":"21","author":"Surpi","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.arr.2026.103149_bib127","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/acs.molpharmaceut.5c00761","article-title":"Nose-to-brain delivery of donepezil hydrochloride via oleic acid-conjugated PAMAM G4 dendrimers for the treatment of Alzheimer\u2019s-like dementia","volume":"23","author":"Suthar","year":"2026","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.arr.2026.103149_bib128","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1007\/s12035-019-1500-y","article-title":"Systematic review of miRNA as Biomarkers in Alzheimer\u2019s disease","volume":"56","author":"Swarbrick","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103149_bib129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103149_bib130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12951-024-02526-0","article-title":"Tau- and \u03b1-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases","volume":"22","author":"Tapia-Arellano","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.arr.2026.103149_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.arr.2026.103149_bib132","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.matpr.2022.10.315","article-title":"Sustainable green synthesized nanoparticles for neurodegenerative diseases diagnosis and treatment","volume":"73","author":"Thukral","year":"2023","journal-title":"Mater. Today Proc."},{"key":"10.1016\/j.arr.2026.103149_bib133","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.arr.2026.103149_bib134","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2016.07.006","article-title":"Retinal nerve fibre layer thickness changes in Alzheimer\u2019s disease: Results from a 12-month prospective case series","volume":"629","author":"Trebbastoni","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2026.103149_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2023.111800","article-title":"Integration of miRNA\u2019s theranostic potential with nanotechnology: promises and challenges for Parkinson\u2019s disease therapeutics","volume":"211","author":"Tryphena","year":"2023","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.arr.2026.103149_bib136","doi-asserted-by":"crossref","first-page":"193","DOI":"10.9758\/cpn.24.1223","article-title":"MIR-26B, MIR-30e, and MIR-206 polymorphisms may play a role in BDNF-mediated development of Alzheimer\u2019s-type dementia","volume":"23","author":"Tuna","year":"2025","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib137","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2217\/nnm-2019-0316","article-title":"Nanoparticles as contrast agents for the diagnosis of Alzheimer\u2019s Disease: a systematic review","volume":"15","author":"Ulanova","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.arr.2026.103149_bib138","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3390\/cells12182279","article-title":"Evaluation of dimercaptosuccinic acid-coated iron nanoparticles immunotargeted to amyloid beta as MRI contrast agents for the diagnosis of Alzheimer\u2019s disease","volume":"12","author":"Ulanova","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.arr.2026.103149_bib139","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12951-024-02648-5","article-title":"Recent advances in gene delivery nanoplatforms based on spherical nucleic acids","volume":"22","author":"Valatabar","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.arr.2026.103149_bib140","article-title":"Nanocarrier-based targeted drug delivery for Alzheimer\u2019s disease: addressing neuroinflammation and enhancing clinical translation","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharm."},{"key":"10.1016\/j.arr.2026.103149_bib141","doi-asserted-by":"crossref","first-page":"16259","DOI":"10.3390\/ijms242216259","article-title":"Potential Implications of miRNAs in the pathogenesis, diagnosis, and therapeutics of Alzheimer\u2019s Disease","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103149_bib142","article-title":"MicroRNAs in Alzheimer\u2019s Disease","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Genet"},{"key":"10.1016\/j.arr.2026.103149_bib143","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","article-title":"The Expression of MicroRNA miR-107 Decreases Early in Alzheimer\u2019s disease and may accelerate disease progression through regulation of \u03b2-site amyloid precursor protein-cleaving enzyme 1","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib144","article-title":"Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis","volume":"11","author":"Wei","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.arr.2026.103149_bib145","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00160","article-title":"MicroRNAs in Alzheimer\u2019s disease: function and potential applications as diagnostic biomarkers","volume":"13","author":"Wei","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2016.00129","article-title":"Getting miRNA therapeutics into the target cells for neurodegenerative diseases: a mini-review","volume":"9","author":"Wen","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib147","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/smll.200400130","article-title":"Nanoscience, nanotechnology, and chemistry","volume":"1","author":"Whitesides","year":"2005","journal-title":"Small"},{"key":"10.1016\/j.arr.2026.103149_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jnt5010001","article-title":"The role of fullerenes in neurodegenerative disorders","volume":"5","author":"Wilson","year":"2024","journal-title":"J. Nanotheranostics"},{"key":"10.1016\/j.arr.2026.103149_bib149","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.3390\/ijms26083905","article-title":"Recent advances in drug development for Alzheimer\u2019s disease: a comprehensive review","volume":"26","author":"Xing","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103149_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.637218","article-title":"The diagnostic value of exosome-derived biomarkers in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis","volume":"13","author":"Xing","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib151","doi-asserted-by":"crossref","DOI":"10.1111\/mec.17749","article-title":"Dynamic and functional miRNA-mediated gene regulations in response to recurrent environmental challenges during biological invasions","volume":"34","author":"Yan","year":"2025","journal-title":"Mol. Ecol."},{"key":"10.1016\/j.arr.2026.103149_bib152","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1021\/acs.jafc.1c00569","article-title":"PLGA-PEG nanoparticles facilitate in vivo anti-Alzheimer\u2019s effects of fucoxanthin, a marine carotenoid derived from edible brown algae","volume":"69","author":"Yang","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.arr.2026.103149_bib153","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-021-00639-1","article-title":"Transferrin-Pep63-liposomes accelerate the clearance of A\u03b2 and rescue impaired synaptic plasticity in early Alzheimer\u2019s disease models","volume":"7","author":"Yang","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.arr.2026.103149_bib154","doi-asserted-by":"crossref","first-page":"9943","DOI":"10.2147\/IJN.S479242","article-title":"Modified Ce\/Zr-MOF nanoparticles loaded with curcumin for Alzheimer\u2019s disease via multifunctional modulation","volume":"19","author":"Yang","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.arr.2026.103149_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.eti.2022.102336","article-title":"Green synthesis of nanoparticles: current developments and limitations","volume":"26","author":"Ying","year":"2022","journal-title":"Environ. Technol. Innov."},{"key":"10.1016\/j.arr.2026.103149_bib156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223781","article-title":"Anti-Alzheimer potential, metabolomic profiling and molecular docking of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea aqueous extracts","volume":"14","author":"Youssif","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2026.103149_bib157","article-title":"Brain-targeted multifunctional micelles delivering Oridonin and Phillyrin for synergistic therapy of Alzheimer\u2019s disease","volume":"87","author":"Yu","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.arr.2026.103149_bib158","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202409986","article-title":"miR-32533 Reduces Cognitive Impairment and Amyloid-\u03b2 Overload by Targeting CREB5-Mediated Signaling Pathways in Alzheimer\u2019s Disease","volume":"12","author":"Zeng","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.arr.2026.103149_bib159","doi-asserted-by":"crossref","DOI":"10.1080\/15476278.2025.2489673","article-title":"MicroRNA-214-3p delivered by bone marrow mesenchymal stem cells-secreted exosomes affects oxidative stress in Alzheimer\u2019s disease rats by targeting CD151","volume":"21","author":"Zhang","year":"2025","journal-title":"Organogenesis"},{"key":"10.1016\/j.arr.2026.103149_bib160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2018.09.011","article-title":"miR-125b promotes tau phosphorylation by targeting the neural cell adhesion molecule in neuropathological progression","volume":"73","author":"Zhang","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2026.103149_bib161","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1453489","article-title":"Assessing and projecting the global impacts of Alzheimer\u2019s disease","volume":"12","author":"Zhang","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.arr.2026.103149_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2020.125288","article-title":"Green synthesis of silver nanoparticles and their preventive effect in deficits in recognition and spatial memory in sporadic Alzheimer\u2019s rat model","volume":"605","author":"Zhang","year":"2020","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.arr.2026.103149_bib163","article-title":"Nanogels as novel nanocarrier systems for efficient delivery of CNS therapeutics","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.arr.2026.103149_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.585432","article-title":"microRNA-based biomarkers in Alzheimer\u2019s Disease (AD)","volume":"14","author":"Zhao","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2026.103149_bib165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/procel\/pwae026","article-title":"Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy","volume":"16","author":"Zheng","year":"2025","journal-title":"Protein Cell"},{"key":"10.1016\/j.arr.2026.103149_bib166","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/brain\/awv383","article-title":"MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer\u2019s disease","volume":"139","author":"Zhu","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103149_bib167","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2011.04.035","article-title":"miR-29c regulates BACE1 protein expression","volume":"1395","author":"Zong","year":"2011","journal-title":"Brain Res."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726001418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726001418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:43:26Z","timestamp":1783025006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726001418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":167,"alternative-id":["S1568163726001418"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103149","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tiny Titans, big promise: Nanotechnology and microRNA in the fight against Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103149"}}